PMA supplement
P890032 S015: CORDIS ORION STEERABLE PTCA CATH. W/GLISSADE HYDRO
FDA PMA supplement · Special (Immediate Track) · Cordis Corp.
Key facts
| Original PMA | P890032 |
|---|---|
| Supplement number | S015 |
| Supplement type | Special (Immediate Track) |
| Reason for the supplement | Other |
| Trade name | CORDIS ORION STEERABLE PTCA CATH. W/GLISSADE HYDRO |
| Generic name | Catheters, transluminal coronary angioplasty, percutaneous |
| Applicant | Cordis Corp. |
| Product code | LOX |
| Received date | Mar 24, 1992 |
| Decision date | Jun 22, 1992 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: